{
    "eid": "2-s2.0-85103137055",
    "title": "Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile",
    "cover-date": "2021-03-11",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "biomarker",
        "head and neck squamous cell carcinoma (HNSCC)",
        "IFN-\u03b3",
        "immune excluded",
        "non-inflamed",
        "real time",
        "Sema4D",
        "soluble"
    ],
    "authors": [
        "Rania H. Younis",
        "Ioana Ghita",
        "Manar Elnaggar",
        "Risa Chaisuparat",
        "Vasileios Ionas Theofilou",
        "Donita Dyalram",
        "Robert A. Ord",
        "Eduardo Davila",
        "Luke J. Tallon",
        "John C. Papadimitriou",
        "Tonya J. Webb",
        "S\u00f8ren M. Bentzen",
        "Joshua E. Lubek"
    ],
    "citedby-count": 8,
    "ref-count": 47,
    "ref-list": [
        "Cancer statistics, 2020",
        "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)",
        "Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study",
        "Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor",
        "Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells",
        "The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review",
        "Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma",
        "Multiparametric immune profiling in HPV- oral squamous cell cancer",
        "Type, density, and location of immune cells within human colorectal tumors predict clinical outcome",
        "Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours",
        "Approaches to treat immune hot, altered and cold tumours with combination immunotherapies",
        "Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy",
        "Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial",
        "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study",
        "IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade",
        "Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition",
        "Liquid Biopsy in Oral Cancer",
        "The Identification of Immunological Biomarkers in Kidney Cancers",
        "Blood-based tumor biomarkers in lung cancer for detection and treatment",
        "The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules",
        "Immune semaphorins: a new area of semaphorin research",
        "Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration",
        "Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation",
        "Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation",
        "CD100 is a leukocyte semaphorin",
        "Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling",
        "Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses",
        "MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D",
        "Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets",
        "Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D",
        "Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively",
        "Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype",
        "Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages",
        "Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer",
        "Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion",
        "Prognostic significance of CD100 expression in soft tissue sarcoma",
        "Increased levels of plasma soluble Sema4D in patients with heart failure",
        "Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications",
        "Semaphorins 4A and 4D in chronic inflammatory diseases",
        "Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma",
        "Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma",
        "Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets",
        "Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma",
        "Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies",
        "Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function",
        "Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody",
        "Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors"
    ],
    "affiliation": [
        {
            "affiliation-city": "Baltimore",
            "@id": "60012957",
            "affilname": "University of Maryland School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012957",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60019720",
            "affilname": "University of Maryland School of Dentistry",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019720",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Alexandria",
            "@id": "60274385",
            "affilname": "Faculty of Dentistry",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60274385",
            "affiliation-country": "Egypt"
        },
        {
            "affiliation-city": "Athens",
            "@id": "60069203",
            "affilname": "Athens University Dental School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069203",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Aurora",
            "@id": "60028392",
            "affilname": "University of Colorado Anschutz Medical Campus",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028392",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60020949",
            "affilname": "University of Maryland Marlene and Stewart Greenebaum Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020949",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Institute for Genome Sciences",
        "School of Dentistry, University of Maryland Baltimore",
        "University of Maryland Baltimore"
    ]
}